Stock Events

Stock Events

Amylyx Pharmaceuticals (AMLX) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.75

-1.09

-0.43

0.23

Details

Expected EPS

-0.704

Actual EPS

-1.07

Surprise EPS

-0.37

Surprise Percent

+51.99%

Description

Amylyx Pharmaceuticals (AMLX) has reported earnings of -1.07 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.